Abstract. Using surface immunoprecipitation at 37°C to "catch" the transient apical or basolateral appearance of an endogenous MDCK lysosomal membrane glycoprotein, the AC17 antigen, we demonstrate that the bulk of newly synthesized AC17 antigen is polarly targeted from the Golgi apparatus to the basolateral plasma membrane or early endosomes and is then transported to lysosomes via the endocytic pathway. The AC17 antigen exhibits very similar properties to members of the family of lysosomal-associated membrane glycoproteins (LAMPS) . Parallel studies of an avian LAMP,
LEP100, transfected into MDCK cells revealed colocalization of the two proteins to lysosomes, identical biosynthetic and degradation rates, and similar low levels of steady-state expression on both the apical (0.8 %) and basolateral (2.1%) membranes . After treatment of the cells with chloroquine, newly synthesized AC17 antigen, while still initially targeted basolaterally, appears stably in both the apical and basolateral domains, consistent with the depletion of the AC17 antigen from lysosomes and its recycling in a nonpolar fashion to the cell surface .
The signals that direct proteins along these pathways are currently the object of intense study (53, 58) . Apical targeting information may be present in the ectodomain of viral glycoproteins (11, 44, 55) and in the glycolipid anchor of proteins attached to the membrane via a glycosyl phosphatidyl inositol linkage (6, 38, 40, 66) . Many rapidly endocytosed proteins are basolaterally distributed (16) (17) (18) 50) , and recent work has suggested a correlation between the presence of signals for coated pit internalization in the cytoplasmic domain and basolateral targeting in MDCK cells. An F. receptor isoform containing an internalization signal is targeted basolaterally, while another isoform differing solely in the cytoplasmic domain and lacking an internalization signal is targeted apically in MDCK cells (26) . A cytoplasmic deletion that confers endocytic properties to the nerve growth factor receptor reverses its polarity from apical to basolateral in transfected MDCK cells (35) . Insertion of a tyrosine in the cytoplasmic domain of apical influenza hemagglutinin (HA), normally excluded from coated pits and poorly endocytosed, results in both coated pit internalization and basolateral targeting (5, 30) . However, the basolateral targeting signal appears to be distinct from the endocytic signal for the polymeric Ig receptor (7) .
In addition to sorting apical and basolateral proteins in epithelia, the TGN also segregates soluble lysosomal enzymes from the secretory pathway. Mannose-6-phosphate (M6P) containing lysosomal enzymes interacts with M6P receptors in the TUN and are then transported within clathrin-coated vesicles to an acidic prelysosomal compartment; here the enzyme dissociates from the receptor and is then transported to lysosomes, whereas the free M6P receptors are recycled back to the TGN (13, 62) . The M6P receptor-rich compartment is referred to as both the prelysosome and the late endosome and the two terms will be used interchangeably throughout the text. At steady state, M6P receptors are predominantly localized to prelysosomes but are also found in the TGN, peripheral endosomes, and the plasma membrane (22) .
Integral membrane lysosomal glycoproteins lack the M6P signal and are still targeted to lysosomes (28) . Lysosomal acid phosphatase (LAP), a transmembrane glycoprotein lacking an M6P signal, is transported via the cell surface to the lysosome, where it is proteolytically cleaved to release soluble enzyme (4, 48, 63) . A family oflysosomal associated membrane glycoproteins (LAMPs) including avian LEP100 (14) , human lamp-1 and lamp-2 (15, 61) , mouse LAMP-1 and LAMP-2 (8, 10) , and rat 1gp110 and 1gpl20 (20, 24) has been described . The surface expression ofLAMPs is low (36, 37) or undetectable (28) . However, deletion of the cytoplasmic tyrosine from the short (11 amino acids) cytoplasmic tail of human lamp-1 inhibits its transport to lysosomes such that it accumulates at the cell surface (65) . It has been proposed that the route of LAMPs to lysosomes is via the same M6P receptor-rich prelysosomal compartment described for proteins containing the M6P lysosomal targeting signal (21) . We show here that an endogenous MDCK lysosomal membrane glycoprotein, recognized by the AC17 monoclonal antibody, exhibits identical properties to transfected LEP100 and transits the basolateral surface and/or early endosomes before delivery to lysosomes.
Materials and Methods

Cells and Materials
MDCK II cells were grown in Dulbeccds minimum essential medium (DMEM) (Gibco Laboratories, Grand Island, NY) supplemented with 5 % fetal bovine serum (Hyclone Laboratories Inc., Logan, UT), glutamine, and nonessential amino acids (Gibco Laboratories) in an air-5% CO2 atmosphere at constant humidity. When grown on filters, 2 x 106 cells were seeded on 24 .5-mm Transwell polycarbonate filters (Costar Corp ., Cambridge, MA) and cultured for 5-7 d with changes of medium every other day. Transepithelial resistance was measured using a Millipore device (Millipore Corp., Bedford, MA) and was typically 200-300 Q-cm2 . Primary cultures of quail fibroblasts were the kind gift of Dr. Takashi Mikawa (Department of Cell Biology, Cornell University Medical College, New York) and were cultured in DMEM supplemented with 10% fetal bovine serum, glutamine, and nonessential amino acids . All chemicals were from Sigma Chemical Co. (St . Louis, MO) unless otherwise indicated . The Stella 2 .1 modeling program was purchased from High Performance Systems (Hanover, NH).
Tlransfection ofLEPI00 cDNA into MDCK Cells
The major EcoRl fragment encompassing the LEP100 cDNA (14) was inserted into the EcoR.I cloning site ofthe pYcos expression vector (41) . Transfection of MDCK cells was performed by a modification of the calcium-phosphate precipitation procedure as described previously (18, 19) . LEP100-expressing clones were selected by immunofluorescence with the CV24 anti-LEP100 mAb (36) . Over 90% of the cells from the LEP-3176 clone expressed LEP100 and this clone was used for all subsequent studies .
Antibodies
The mouse AC17 mAb (IgGi) was produced by immunization of BALB/c mice with MDCK cells detached with PBS/EDTA and injected intraperitoneally (106 cells/mouse) . Boosts with the same material were done at days 20, 40, 51, 52, and 53 and the mouse was killed at day 54 . HybridThe Journal of Cell Biology, Volume 115, 1991 omas between spleen cells and NS1 myeloma cells were produced as previously described (31) . Hybridoma supernatants were screened by immunofluorescence of wounded MDCK monolayers and positive clones were subcloned twice by limiting dilution . Ascites fluid was produced from the intraperitoneal injection of 3 x 106 AC17 hybridoma cells into pristane treated BALB/c mice . Scatchard analysis ofbinding to AC17 antigen in fixed permeabilized cells shows a Kd of -5 nM for the AC17 mAb. For some experiments monoclonal IgGs were purified from ascites fluids and 125I-iodinated by the iodogen method (56) . A polyclonal rabbit antiserum was generated by immunizing rabbits with the peptide KSHAGYQTI, corresponding to the COOH terminus of the cytosolic tail of avian LEP100 and mammalian LAMPI, covalently linked to keyhole limpet hemocyanin. Antipeptide antibody was isolated by amity chromatography on a peptide column .
Metabolic Labeling
Confluent monolayers of LEP-3F6 MDCK cells grown on filters for 5-7 d were incubated in methionine/cysteine-free DMEM containing 0.2% BSA for 30 min and then pulse-labeled with 35 S-Express (160 uCi/filter ; New England Nuclear, Boston, MA) for 20 min on the basolateral surface . Steadi y-state metabolic labeling was performed by the incubation of filters with 5 S-Express (80 jaCi/filter) in methioninelcysteino-free DMEM supplemented with 0.1 vol complete medium overnight . Cells were chased in complete medium supplemented with cold methionme and cysteme as doscribed for individual experiments before lysis of the cells.
Immunoprecipitation and Immunoblots
The AC17 antigen and LEP100 were immunoprecipitated by incubation of cell lysates with protein A-Sepharose beads (Pharmacia LKB Biotechnology Inc ., Piscataway, NJ) coated sequentially with rabbit anti-mouse antibodies (Cappel Laboratories, Malvern, PA) and the AC17 or CV24 mAbs, respectively, as previously described (32) . For endoglycosidase F (endo F) and endoglycosidase H (endo H) (Boehringer Mannheim Corp., Indianapolis, IN) treatments, the immunoprecipitates were eluted by boiling for 5 min in 0.1% SDS and 0.1 M sodium citrate containing a protease inhibitor mix and digested with 0.1 U endo F for 6 h or 1 mU of endo H for 16 h at 37°C . The immunoprecipitated samples were analyzed by SDS-PAGE 8 % (29) and the dried gels were processed for fluorography (9) . Where indicated, MDCK cells were extracted with 1% Triton X-114 (3) and the detergent and aqueous phases formed at 37°C were analyzed by SDS-PAGE and protein blotting onto nitrocellulose as previously described (60) and AC17 mAb binding revealed with 125 1-protein A (New England Nuclear). Autoradiographs were obtained from radiolabeled gels and blots using preflashed film (Eastman Kodak Co., Rochester, NY) . Quantitation of the intensity of labeled bands was taken from the average of three passes through the left, middle, and right areas of an individual band using a scanning densitometer (model GS300; Hoefer Scientific Instruments, San Francisco, CA) . Comparisons were made between bands of intensities falling within the linear response range of the densitometer.
Surface Immunoprecipitation
Cells on filters pulse-labeled with 35 S-Express for 20 min in methionine cysteine-free medium were chased at 37°C in the presence of normal medium containing AC17 mAb (50x diluted ascites fluid, final mAb concentration -100 ug/ml) in the apical (0.5 ml) or basolateral (1 ml) medium for the indicated period of time . The filters were washed five times for 15 min with PBS/CM containing 0.5% BSA at 4°C. The cells were lysed at 4°C in lysis buffer (1% Triton X-100, 20 mM Tris, pH 8,150 mM NaCl, 5 mM EDTA, 0.2% BSA, and a mix of protease inhibitors) and precleared for 1 h with BSA conjugated to CNBr-activated Sepharose 4B (Pharmacia LKB Biotechnology Inc.) . Antigen-antibody complexes were precipitated at 4°C for 2 h with rabbit anti-mouse protein A-Sepharose beads and analyzed by SDS-PAGE and fluorography as described above .
Biotin Hydrazide Labeling ofSurface Glycoproteins
Exposed glycoproteins on the surface of MDCK cells were labeled as previously described with minor modifications (39) . To enhance detection, confluent monolayers of LEP3176 MDCK cells were incubated twice for 30 min with 10 mM periodate and then twice for 30 min with 2 mM biotin-Xhydrazide (Calbiochem Corp., La Jolla, CA) added at 4°C to either the a cal or basolateral surfaces before immunoprecipitation, blotting, and '91 1: streptavidin labeling .
Immunofluorescence
Procedures for indirect immunofluorescence of MDCK cells were as described (52) . For intracellular staining, cells fixed with 3% paraformaldehyde were permeabilized with 0.075 % (wt/vol) sapomn. 0.5-wm frozen sections of MDCK cells on collagen (32) were processed for immunofluorescence as described (59) . Fluorescent double labeling of cells was performed with the AC17 and CV24 niAbs using FIX-conjugated CV24 mAb or with the AC17 mouse mAb and polyclonal rabbit and-tail peptide antibody. Endocytosis of the CV24 and AC17 mAbs was assayed as previously described (65) . All fluorescent secondary antibodies were purchased from Jackson ImmunoResearch Laboratories, Inc. (West Grove, PA) . Fluorescently labeled cells on cover slides were mounted in gelvatol (Monsanto Chemical Co., St . Louis, MO) and photographed with a Leitz Ortholux epifiuorescence microscope using 400 ASA TMAX film (Kodak) .
Immunoperoxidase Labeling and Electron Microscopy
Immunoperoxidase localization of the AC17 antigen and LEPI00 to lysosomes was performed as previously described (36) . Immunolabeled samples were postfixed in 1 % osmium tetroxide, dehydrated in a graded ethanol series, and embedded in Epon . Thin sections were observed in an electron microscope (JEOL U.S.A . Inc ., Peabody, MA) .
Results
Expression ofLAMPS in MDCK Cells
Monoclonal antibodies generated against MDCK proteins were screened by immunofluorescent labeling of wounded MDCK monolayers . One monoclonal antibody, designated acteristic of lysosomes ( Fig. 1) . To characterize the expression of this protein, an exogenous lysosomal glycoprotein, avian LEP100, was transfected into MDCK cells (14, 36, 37) . Gentomycin-resistant clones were selected for LEP100 expression by immunofluorescent labeling with the CV24
anti-LEP100 mAb . All expressing clones exhibited a typical lysosomal fluorescent staining pattern and one such clone, labeled LEP-3F6, was used for all subsequent studies . LEP100 expressed in MDCK cells has a molecular mass of 110 kD compared with the 100 kD of the endogenous protein expressed in quail fibroblasts (Fig. 2 ) . Endo F digestion to remove N-linked oligosaccharides revealed that the polypeptide core of both exogenously expressed LEP100 in MDCK cells and endogenous LEP100 in quail fibroblasts had an identical size of 46 W, as previously reported (36) . The increased apparent molecular weight of LEP100 in MDCK cells is probably the result of differences in the structure of the complex N-linked oligosaccharide chains . The AC17 mAb recognizes a glycoprotein of 95 kD in MDCK cells, which when digested by endo F yields a product of 40 kD ( Fig . 2) , different from LEP100 but characteristic of lysosomal membrane glycoproteins (28) . There is no crossreactivity between the two antibodies : the AC17 antibody does not react with chicken fibroblasts (data not shown) and CV24 does not crossreact with MDCK cells (Fig . 3) . After extraction with Triton X-114 the AC17 antigen partitions predominantly in the detergent phase, indicating that it is an integral membrane glycoprotein (Fig . 2 C) . The vesicular structures immunofluorescently labeled by the AC17 mAb were determined to be lysosomes by the complete colocalization of the AC17 antigen with transfected LEP100 as well as with the endogenous antigen recognized by a rabbit polyclonal antibody raised against a synthetic peptide corresponding to the conserved carboxy-terminal amino sequence of the cytoplasmic tail of mammalian LAMP-1 (Fig. 3) . Immunoperoxidase electron microscopy with the CV24 and AC17 mAbs revealed characteristic lysosomal structures (Fig. 4 ) .
Processing and Lifetime ofLysosomal Glycoproteins in MDCK Cells
To determine the rate of passage of newly synthesized AC17 antigen and LEP100 through the Golgi, pulse-chase experiments were carried out on LEP3F6 cells (Fig. 5 A) . The immunoprecipitated proteins were treated overnight with endo H to remove unprocessed high-mannose oligosaccharide chains . As previously described, both proteins acquire endo H resistance with a t i/2 of 25 min, reflecting the kinetics of their transport to the Golgi apparatus (36) .
The extensive glycosylation of lysosomal glycoproteins endows them with resistance to lysosomal degradation and an extremely long lifetime within the cell (28) . Pulse-chase labeling of LEP3F6 MDCK cells with [ 31 S] isotope-free medium revealed that in MDCK cells both transfected LEP100 and endogenous AC17 antigen are extremely stable proteins . Both proteins are synthesized as precursors of lower molecular weight and acquire their mature size within 1 h of chase (Fig . 5 B) . Approximately 70% of the pulse-labeled LEP100 and AC17 antigen are still present after 23 h of chase, which, when extrapolated, indicates a t z of 120-150 h for both proteins.
Surface Expression of the AC17Antigen and LEP100 in MDCK Cells
The extensive glycosylation of lysosomal glycoproteins allowed us to detect both LEP100 and AC17 antigen by periodate oxidation of cell surface carbohydrates and reaction with biotin-X-hydrazide followed by immunoprecipitation and "11-streptavidin blotting (Fig . 6 ) . Equivalent amounts of the two proteins were detected on the apical and basolateral surfaces . In chick embryo fibroblasts 2-3% of total cellular LEP100 is found on the cell surface by radioimmunoassay (37) . Using a similar approach with iodinated AC17 and CV24 mAbs we determined the apical, basolateral, and intracellular distribution of AC17 antigen and LEP100 in LEP3F6 MDCK cells (Table I) . Both proteins were localized predominantly intracellularly (97 %) with 0.8 % of the total cellular protein found on the apical surface and 2.1% on the basolateral surface . Pretreatment of the cells for 5 h with 0.1 mM chloroquine resulted in an approximately twofold increase in the apical expression but had no effect on the basolateral expression of either protein (Fig . 6 ) .
Surface Immunoprecipitation ofLysosomal Membrane Glycoproteins
Anti-LEP100 antibodies added to viable chicken fibroblasts are specifically taken up by surface-expressed LEP100 and transported to lysosomes (36, 37) . Similarly, anti-lamp-1 antibodies added to h-lamp-1 transfected COS cells at 37°C are Nabi transported to lysosomes (65) . We have used a similar approach to study the surface expression of lysosomal glycoproteins in MDCK cells. As seen in Fig . 7 
We used the ability to "catch" lysosomal glycoproteins by the addition of antibodies to the culture medium to study the domain-specific passage of newly synthesized MDCK lysosomal glycoproteins . To ensure that lysosomal glycoprotein surface expression was not due to the redirection ofan overexpressed transfected protein to the cell surface, we studied the trafficking of the endogenous MDCK lysosomal membrane glycoprotein recognized by the AC17 mAb . Cells were pulse labeled with [35S]methionine and cysteine for 20 min, chased in the absence of antibody for 10 min, and then incubated with the AC17 mAb in the apical or basolateral chase media for 45, 90, or 180 min. As seen in Fig . 8, AC17 antigen is detected basolaterally within 45 min . Extended incubation with antibody for 180 min on the basolateral surface results in a decreased detection of the antigen, perhaps reflecting arrival of the antigen-antibody complex to lysosomes were the acidic intraluminal pH may disrupt antigen-antibody interaction . No AC17 antigen was detected apically at any time point, indicating that newly synthesized AC17 antigen is targeted to the basolateral domain, encom- 45, 90, or 180 min in the presence of the AC17 mAb added to the apical or basolateral surface as indicated . Antigen-mAb complexes were recovered from detergent extracts of the cells by immune precipitation and the labeled AC17 antigen was detected by SDS-PAGE and fluorography. AC17 antigen could not be detected apically in the absence of chloroquine (-Chlor) but appeared apically, although retarded relative to its basolateral appearance, after treatment of the cells for 5 h with 0.1 mM chloroquine (+Chlor) .
passing both the basolateral cell surface and basolateral early endosomes, before transport to lysosomes . The lack of 35 S-labeled AC17 antigen detected apically precludes the possibility that 35 S-labeled AC17 antigen was precipitated due to fluid phase uptake and transport of the antibody to prelysosomes or lysosomes or resulted from antibody exchange with labeled molecules during subsequent experimental manipulations .
Effect of Chloroquine on Targeting of theACl7Antigen
After treatment of cells for 5 h with 0.1 mM chloroquine, expression of the AC17 antigen does not decrease with time in the basolateral domain and can be detected in significant amounts in the apical domain consistent with the enhanced surface expression of LEP100 in chloroquine-treated fibroblasts ( Fig . 8) (37) . The de novo appearance of AC17 antigen in the apical domain following chloroquine treatment corresponds to the increase in steady-state AC17 antigen levels detected on the apical surface by biotin hydrazide labeling (Fig . 6 ) . Apical appearance is delayed relative to basolateral appearance and detection of the AC17 antigen after antibody incubation for 180 min is not decreased, consistent with the depletion of LAMPs from lysosomes in the presence of chloroquine (37) .
Targeting of the AU7Antigen
To follow the time course of basolateral expression of newly synthesized AC17 antigen, surface-capture by AC17 antigen was monitored both apically and basolaterally for discrete time periods after pulse labeling with [s5 S]methionine/cysteine. The newly synthesized AC17 antigen appeared transiently basolaterally with a t112 of appearance of 35 min, comparable to the surface delivery of basolateral surface proteins in MDCK cells (33) . Expression peaked 60 min after the pulse and then diminished with a tz of 35 min, indicating the removal of the AC17 antigen from the surface and early endosomes and its redirection to lysosomes . Considering the time required for exit from the Golgi (t 12 = 25 min based on acquisition of endo H resistance), the rapid transit Nabi et al . Lysosomal Targeting in MDCK Cells of the AC17 antigen to the basolateral domain is not consistent with its prior delivery to lysosomes (Fig . 11) . No apical 35 S-labeled antigen was detected at any time point, suggesting that the AC17 antigen is routed from the Golgi apparatus exclusively to the basolateral surface or basolateral early endosomes. As seen in Fig . 8 , in the presence of chloroquine newly synthesized AC17 antigen is targeted basolaterally and is then more stably expressed in both the apical and basolateral domains (Fig. 9 B) , consistent with the nonpolar distribution of lysosomes in MDCK cells (Fig . 1) .
74% of Newly SynthesizedAC17Antigen Pusses through the Basolateral Domain
The efficient surface capture achieved in the short 15-min antibody incubations of the targeting experiments (Fig. 9 ) strongly suggests that precipitated AC17 antigen interacts with the antibody on the surface, or perhaps within basolateral early endosomes, but not within late endosomes (prelysosomes), since these are reached by fluid phase endocytosis in MDCK cells only after 15 min from both the apical and basolateral surfaces (2, 47) . Furthermore, addition of antibody for even shorter periods, such as 5 or 10 min, results in the precipitation of AC17 antigen in amounts proportional to the time of incubation (Fig . 10 A) , precluding interaction of the AC17 antibody with its antigen in prelysosomes .
To determine whether the basolateral expression of the AC17 antigen is due to mistargeting of lysosome-bound pro- , and 100 min after the pulse, the AC17 mAb was added in medium to the apical or basolateral surface for 15 min and captured AC17 antigen was analyzed as in Fig . 8 . The AC17 antigen was not detected apically and arrived to and disappeared from the basolateral domain with a t 2 of -35 min. In B, the cells were treated with 0.1 mM chloroquine for 5 h before surface immunoprecipitation and the AC17 mAb was added at two additional time points of 120 and 140 min after the pulse. Apical AC17 antigen could be detected after chloroquine treatment, but its delivery was retarded relative to basolateral delivery. Figure 10 . Quantitation of surface appearance of the AC17 antigen . (A) After 50 min of chase following a 20-min pulse of ["S]methionine/cysteine, the AC17 mAb was added to the basolateral medium for 5, 10, 15, or 20 min . The amount of AC17 antigen captured in these short time periods is compared with that captured by addition of antibody to the basolateral surface from 10 to 90 min after the pulse (Surf) and to the total AC17 'SS-labeled antigen precipitated from detergent extracts with AC17 immunobeads (RI) . (B) After a 20-min pulse or overnight labeling, the AC17 mAb was added to either the apical (Ap) or basolateral (BI) surfaces from 10 to 90 min after the end of the labeling period . An identical filter chased in the absence of antibody was lysed and the AC17 antigen immunoprecipitated by addition of AC17 invnunobeads to the lysate (RI) . After a pulse labeling, 74 f 12 % (n = 5) of the total immunoprecipitable AC17 antigen could be recovered by surface immunoprecipitation .
tein to the cell surface or whether basolateral passage is the constitutive route for the AC17 antigen to the lysosome, the amount of AC17 antigen that could be detected by the addition of antibody to the basolateral medium was quantified . After a 20-min pulse, cells were chased in the presence of AC17 antibody on the apical or basolateral surface from 10 to 90 min, the time of basolateral delivery determined from Fig . 9 . A parallel culture was chased in the absence of mAb, lysed, and then immunoprecipitated to determine the total amount of labeled AC17 antigen in the sample (Fig . 10 B) . While no AC17 antigen was detected apically, as expected, 74 f 12 % (n = 5) of the total immunoprecipitable protein was recovered by basolateral surface immunoprecipitation .
In contrast, after overnight labeling to generate a steadystate pool of labeled molecules, a small proportion of total labeled AC17 antigen was detected both apically and basolaterally (Fig . 10 B) . While the basolateral signal is clearly greater than the apical signal, the extended exposure required to visualize the surface immunoprecipitated protein, resulting in overexposure of the total protein band and appearance of a background band just above the AC17 antigen, made quantification of the apically and basolaterally expressed AC17 antigen difficult. The detection of small amounts of the AC17 antigen both apically and basolaterally by surface immunoprecipitation after overnight labeling corroborates our finding by 'III-labeled mAb binding and by biotin hydrazide surface labeling that the AC17 antigen is found on both surfaces at steady state . The greater basolateral accumulation of AC17 antigen and LEP100 may be due in part to the continual targeting of newly synthesized molecules to that domain . The discrepancy in degree and polarity of the distribution of surface immunoprecipitated'SS-labeled AC17 antigen after pulse and overnight metabolic labeling is best explained by the polar delivery of the AC17 antigen via the basolateral surface and early endosomes to prelysosomes and lysosomes from which it shuttles in small amounts, as reported for LEP100 in chick fibroblasts (37) , to both the apThe Joumal of Cell Biology, Volume 115, 1991 ical and basolateral surface domains in a nonpolar fashion (Fig . 11) .
Discussion
To characterize the pathway to lysosomes in epithelial cells, we have studied the expression of an endogenous lysosomal membrane glycoprotein in MDCK cells . A monoclonal antibody, AC17, recognizes distinct vesicular structures by immunofluorescent labeling. These structures were identified Figure 11 . Schematic representation of the trafficking of the AC17 antigen . (A) After biosynthesis, newly synthesized AC17 antigen is targeted from theGolgi apparatus (G) to the basolateral plasma membrane and/or early endosomes and from there transferred to lysosomes (L) via basolateral early endosomes (EE(BL)) and prelysosomes (PL ; heavyarrows) . The AC17 antigen recycles at low levels from lysosomes to prelysosomes and the apical and basolateral domains (dashed arrows) . In the presence ofchloroquine,the movement of the AC 17 antigen from the prelysosome to lysosome is blocked (6) and recycling with both the apical and basolateral domains accentu ated (a) . The diagram represents the fusion of vesicles budding off the TUN with basolateral early endosomes and cell surface recycling from the prelysosome . However, our results cannot distinguish between targeting from the TGN directly to the basolateral surface orthrough an early endosomal compartment nor determine from which intracellular compartment recycling occurs. (B) Using the Stella modeling program on a Macintosh computer, a model was generated incorporating the various steps of AC17 trafficking outlined in A. Using the known parameters ofacquisition of endo H resistance in the Golgi apparatus (circles) and basolateral appearance (squares) and assuming similar kinetic parameters for AC17 endocytosis and recycling as described for LEP100 in chick fibroblasts (37), the Stella program generated a model consistent with the rapid passage of the AC17 antigen to lysosomes (LYS) . The model incorporated the experimental data of passage through the Golgi (Fig. 5 A) , basolateral expression (Fig. 9) , and lysosomal degradation (Fig. 5 B) of the AC17 antigen . Rate constants for the distribution and shuttling of LEP100 in chick fibroblasts (37) were used to describe the endocytosis (k 1 = 0.33 min-'), exocytosis (k-1 = 0.16 min -1), and shuttling from endosome to lysosome (k2 = 0.067 min-) . A fivefold decreased rate of recycling from lysosome to endosome (k-2 = 0.00083 min') of the AC17 antigen, relative to LEP100, was used due to the minimal effect of chloroquine on steady-state AC17 antigen surface expression in MDCK cells (Fig.  6 ) compared with that found for LEP100 in chick fibroblasts (37) . Not unexpectedly, this change was not found to significantly affect the rate of arrival of the AC17 antigen to lysosomes. 1b simplify the model a single endosomal compartment was used corresponding to the early endosome. Altering of the modelto incorporate targeting of vesicles from the Golgi to either the plasma membrane or the early endosome did not significantly affect the rate of arrival of the AC17 antigen to the lysosome .
as (28) . In MDCK cells, the AC17 antigen colocalizes with transfected LEP100, the avian LAMP (14, 36, 37) , and an endogenous MDCK antigen recognized by a polyclonal antibody raised against the highly conserved cytoplasmic tail of LEP100 (Fig. 3) ; the labeled structures exhibited a typical lysosomal morphology by immunoelectron microscopy (Fig. 4) . LAMPs typically have a molecular size between 100 and 120 kD with a core protein of -40 kD. They are synthesized as precursor molecules of 90 kD containing 17-20 N-linked high mannose oligosaccharides that are processed to complex oligosaccharides containing a large amount of polylactosamines (28) . The endogenous MDCK lysosomal glycoprotein recognized by the AC17 monoclonal antibody partitions to the detergent phase following Triton X-114 extraction, is synthesized as a precursor molecule of 85 kD, has a molecular size of 95 kD, and has a core polypeptide of40 kD. The time course of acquisition ofendo H resistance and of protein degradation for the AC17 antigen is identical to that of LEP100 expressed in the same transfected MDCK clonal cell line. These characteristics strongly indicate that the AC17 antigen is an endogenous MDCK LAMP
In chick fibroblasts, LEP100 has been shown to be localized primarily to lysosomes (90%) but is also present in the plasma membrane (3 %) and in endosomes (7%) (36, 37) . Other LAMPs are barely detectable at the cell surface (28) . By three different methods, we demonstrated low levels of surface expression of both transfected LEP100 and the endogenous AC17 antigen on the apical (0.8%) and basolateral (2 .1%) membranes of MDCK cells. LEP100 mAb added to chick fibroblasts at 37°C is specifically endocytosed to lysosomes, as are LAMP antibodies added to h-lamp-1 transfected cells (37, 65) . Similarly, both AC17 and CV24 mAbs were taken up by LEP-3F6 MDCK cells and delivered to lysosomes (Fig. 7) . The inability of untransfected MDCK cells to take up anti-LEP100 demonstrates the specificity of this delivery from the cell surface to lysosomes .
Interestingly, in contrast to its nonpolar steady-state surface distribution, newly synthesized AC17 antigen was targeted in a highly polar fashion. After a [35S]methionine/ cysteine metabolic pulse, the AC17 antigen was surface immunoprecipitated by the continuous addition ofmAb at 37°C to the apical or basolateral medium; antibody-antigen complexes formed were collected by precipitation after cell lysis . Newly synthesized AC17 antigen couldonly be detected after addition of antibody basolaterally ; extended incubation (180 min) resulted in a decreased signal, probably due to the arrival of antigen-antibody complexes to the lysosome . Addition of antibody for discrete (15 min) time periods indicate a tan of delivery to and removal from the basolateral domain ofti 35 min, in agreement with kinetic studies ofsurface expression ofLEP100 inchick fibroblasts, which revealed an extremely short residence time at the plasma membrane (t an = 2 min) . In contrast, continuous presence of antibody in the apical medium during the chase detected no AC17 antigen . Apical and basolateral fluid phase markers have been shown to mix 15 min after addition of fluid phase marker in Nabi et al . Lysosomal Targeting in MDCK Cells a late endosomal (prelysosomal) compartment (2, 47) . The absence of apical detection andour ability to detect AC17 antigen after addition of basolateral antibody for only 5 min (Fig. 10) indicates that we are detecting AC17 antigen at the basolateral cell surface or within basolateral early endosomes and not within prelysosomes reached by fluid phase uptake of antibody.
These results contrast with a previous report (21) , which suggested that two integral membrane lysosomal glycoproteins, 1gpll0 and lgp120, are not targeted to lysosomes in fibroblasts via the cell surface but rather through an acidic prelysosomal compartment, the route followed by M6P containing lysosomal hydrolases (62). This conclusion was based on the inability to detect lgp's at the cell surface and on the rapid delivery of these proteins to lysosomes (t1rz = 45 min), which, when compared with the rates of plasma membrane protein delivery to the cell surface and of membrane bound endocytic markers to lysosomes, was judged to preclude a passage of lysosomal glycoproteins through the cell surface. The low levels of surface expression of LAMPs could be ascribed to reequilibration ofthe proteins between lysosomes and the cell surface or to missorting in the Golgi due to oversaturation of sorting receptors, and would not reflect the major pathway of LAMPS out of the Golgi (28). Our ability to detect the transient surface expression of a LAMP during biogenesis may be attributed to the approach utilized (antibody "catch") and to the possession of a high affinity monoclonal antibody against an endogenous MDCK LAMP (Kd = 5 nM) . Addition of the AC17 mAb to the basolateral medium from 10 to 90 min after pulse labeling, encompassing the peak of AC17 antigen basolateral appearance, resulted in the recovery of 74 f 12% (n = 5) of the total precipitable AC17 antigen. Considering the loss inherent to any immunoprecipitation procedure and the possible disruption of some antigen-antibody complexes upon arrival to lysosomes, the detection of 74 % of the total protein pulse by surface immunoprecipitation indicates that newly synthesized AC17 antigen is targeted basolaterally before delivery to lysosomes .
The time course of AC17 antigen basolateral delivery is similar to that described for the vectorial targeting of basolateral proteins in MDCK cells (33) and is consistent with the rapid delivery of LAMPs to lysosomes described previously (21) . The AC17 antigen acquires endo H resistance with a tan of 25 min and is detected basolaterally with a t1n of 35 min such that transport from the Golgi apparatus tothe basolateral domain requires -10 min . Considering the short residence time of LEP100 on the cell surface and its rapid transport to lysosomes (37) , these values support the delivery ofthe AC17 antigen to lysosomes via the cell surface and early endosomes with a tan of 45-60 min. Computer modeling of the pathway of the AC17 antigen to lysosomes incorporating the known parameters of acquisition of endo H resistance in the Golgi apparatus and passage of the AC17 antigen through the basolateral domain confirm that the basolateral targeting of the AC17 antigen is consistent with its rapid delivery to lysosomes (Fig. 11) . Similar rates of arrival of the AC17 antigen to lysosomes were predicted from models incorporating either direct vesicular fusion with the basolateral surface or fusion with early endosomes and rapid recycling between the early endosome and the basolateral 158 1 surface. It is therefore possible that some AC17 antigen may be transported to the lysosome by way of basolateral early endosomes without appearing on the cell surface.
The detection of AC17 antigen surface expression by addition of antibody at 37°C does not rule out the possibility of fluid phase endocytosis of antibody and its interaction with antigen in basolateral early endosomes . Endocytosed alpha2-macroglobulin, which is targeted to lysosomes after release from its receptor within the early endosome, reaches a compartment inaccessible to fluid phase uptake (fusioninaccessible) with a t,a of 8 min (57). AC17 antigen endocytosis may be better represented by studies oflysosome targeted transmembrane VSV G protein implanted into the plasma membrane and then crosslinked by antibody which reaches a fusion-inaccessible compartment with a tv2 of <5 min (23) . AC17 antigen that transited only the early endosome en route to lysosomes would therefore reside in a compartment accessible to fluid phase uptake of antibody for a very short period of time and we question whether our results can be explained by AC17 antibody-antigen interaction within intracellular compartments . The significantly greater rate of endosome to surface recycling (0.138 mint) relative to the rate of endosome to lysosome transport (0.076 mint) measured for LEP100 in chick fibroblasts (37) suggests that any LAMP molecules that reach the early endosome must necessarily also be expressed on the cell surface, ifonly very transiently. Whatever the route taken, it is clear that the AC17 antigen transits a compartment rapidly accessible to antibodies within the basolateral but not the apical medium, either the plasma membrane or the early endosome, and therefore does not follow the direct TGN-prelysosome route to lysosomes which has been described for lysosomal hydrolases (13, 62) .
In the presence ofchloroquine, the expression ofthe AC17 antigen in MDCK cells was dramatically altered . Newly synthesized protein was still targeted first basolaterally, although with slower kinetics, and could then be detected for extended times in both the apical and basolateral domains . Chloroquine has been shown to selectively block the pathway of LEP100 to lysosomes, resulting in its depletion from lysosomes and increased presence in endosomes and the plasma membrane (37) . The increased surface residence time and the apical appearance of the AC17 antigen probably reflect its arrival to an intracellular compartment from which the protein can recycle to both the apical and basolateral domains . This compartment is probably the prelysosome (late endosome) where fluid phase markers endocytosed from the apical and basolateral surfaces have been shown to meet (47) . This suggests that chloroquine specifically blocks the path of the AC17 antigen from the prelysosome to the lysosome and that recycling with early endosomes and the plasma membrane occurs from the prelysosome. Newly synthesized AC17 antigen is therefore targeted to the basolateral surface and/or early endosomes, endocytosed, and then transferred via the endocytic pathway to lysosomes from which it reequilibrates with prelysosomes and both apical and basolateral early endosomes and plasma membranes (Fig. 11) .
The basolateral appearance of the AC17 antigen en route to lysosomes is consistent with the finding that the pathway of LAP, a transmembrane lysosomal enzyme lacking M6P, to lysosomes is via the cell surface (4) . LAP is rapidly transThe Journal of Cell Biology, Volume 115, 1991 ported from the Golgi apparatus to the cell surface (in 10 min) and recycles between the cell surface and endosomes more than 15 times before transport to lysosomes with a t,rz of 6-7 h (4) . Deletion of the cytoplasmic domain of LAP or replacement of the tyrosine within the cytoplasmic domain with another amino acid results in accumulation of the protein at the cell surface (48) . Similarly, a tyrosine residue in the cytoplasmic domain is critical for the targeting of h-lamp-1 to lysosomes (65) . The cytoplasmic tyrosine-containing motif, while clearly an endocytic signal, is not in itselfsufficient to target proteins to lysosomes since it is present in a number of receptors that recycle from endosomes to the plasma membrane (12, 27) . Additional unknown features may be required to target proteins to lysosomes. Ongoing studies ofAC17 antigen expression in MDCK cells will help define the mechanisms involved in this novel biogenetic pathway in polarized epithelia .
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Note Added in Proof. Sequencing by Edman degradation of 20 NH,-terminal amino acids of AC 17 antigen immunopurified from dog kidney has revealed significant sequence identity to human and mouse .LAMP-2 . 15 of 18 identifiable amino acids are identical to human LAMP-2 and two ofthe nonidentical amino acids are present in the mouse LAMP-2 sequence . The high degree of sequence identity indicates that the AC17 antigen is the dog homologue of the LAMP-2 family of lysosomal membrane glycoproteins .
